Details for Patent: 4,873,080

Summary for Patent: 4,873,080

Title:	Oral anti-diabetic pharmaceutical compositions and the preparation thereof
Abstract:	Galenic compositions containing an oral antidiabetic agent and having an improved release of active substance as well as processes for producing these compositions are provided. The pharmaceutical compositions are characterized in that the onset of the activity and the duration of activity are adapted to the particular needs of diabetics with regard to proper control of metabolism and the associated proper release of insulin. A basic or acidic excipient in a solvent is added to the anti-diabetically active substance in a quantity such that the active substance is made soluble, and then a solubilizing agent is added. The solution is applied to a water-insoluble carrier, the solvent is evaporated, and the residue is further processed to yield the various compositions.
Inventor(s):	Brickl; Rolf (Warthausen, DE), Schepky; Gottfried (Biberach, DE), Rupprecht; Eckhard (Aulendorf-Tannhausen, DE), Greischel; Andreas (Biberach, DE)
Assignee:	Dr. Karl Thomae GmbH (Biberach an der Riss, DE)
Application Number:	07/103,524
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 4,873,080

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,873,080

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	3320583	Jun 08, 1983

International Family Members for US Patent 4,873,080

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	49886
Australia	2924184
Australia	562803
Canada	1228300
German Democratic Republic	223360